Related Experiment Videos

A case report of intravenous leiomyomatosis extending into the heart

Y Itani1, Y Otsuka, F Deguchi

  • 1Third Department of Internal Medicine, Chiba University School of Medicine, Japan. itani-y@mtg.biglobe.ne.jp

Heart and Vessels
|January 5, 2002
PubMed

Insights

A woman with uterine leiomyoma developed intracaval and intravenous tumors, diagnosed as leiomyomas. These intravenous leiomyomas extended into the heart, a rare condition.

Area of Science:

  • Cardiovascular Medicine
  • Oncology
  • Gynecologic Pathology

Background:

  • Intravenous leiomyomatosis is a rare condition characterized by benign smooth muscle tumors that grow along vascular channels.
  • Uterine leiomyomas are common benign tumors of the uterus, typically confined to the uterine wall.

Observation:

  • A 47-year-old woman, previously treated for uterine leiomyoma, presented with intracaval and intravenous tumors.
  • Diagnostic imaging, including ultrasonic cardiography, MRI, CT, and venography, confirmed the presence of these tumors.
  • Surgical removal of the tumors was performed.

Findings:

  • Pathological examination confirmed the tumors were leiomyomas.
  • The findings indicated intravenous leiomyomatosis extending into the heart, a rare and aggressive manifestation.

Implications:

  • This case highlights the potential for uterine leiomyomas to manifest as intravenous leiomyomatosis with intracardiac extension.
  • Early diagnosis and complete surgical resection are crucial for managing this rare condition.
  • Further research is needed to understand the pathogenesis and optimize treatment strategies for intravenous leiomyomatosis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...